date:Jul 15, 2014
the license for commercial production of all parts of the hemp plant including the extraction of CBD and other non-psychoactive cannabinoids.
Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934, as amended, filed with the Securities and Exchange Commission's EDGAR database.